Clinical Trial Update: Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years [Phase 2]

View source ↗

Summary

Completed Phase 2 trial evaluating treatment at diagnosis for mantle cell lymphoma in patients under 65.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED